TERAIMMUNE
Developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
TERAIMMUNE
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2016-09-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.teraimmune.com
Total Employee:
11+
Status:
Active
Contact:
301-232-4105
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag
Similar Organizations
Aluda Pharmaceuticals
Aluda Pharmaceuticals discovers and develops innovative therapeutics broadly applicable to autoimmune diseases and cancer.
Bento lab
Bento·lab is a powerful, personal laboratory that enables scientists, artists.
Celmed Biosciences
Celmed BioSciences develops cell therapy-based treatments for hematological, immunological, and neurological disorders.
Co.Don
Co.Don engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide.
Complement Pharma
Complement Pharma is a developer of monoclonal antibody intended to treat neurodegenerative and immune-mediated disorders.
Drift Biotechnologies
Drift Biotechnologies develops bioinformatics software for infectious disease genetic sequencing.
Immplacate
Immplacate is a preclinical stage cell therapy company.
JURA Bio
Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders.
Map My Gene
Map My Gene offers DNA inborn talents and traits testing and disease susceptibility genetic testing services.
NuPhY
NuPhY grows DNA-verified, true-to-type, disease, and production of the highest quality virus-free plant material.
Current Employees Featured
Founder
Official Site Inspections
http://www.teraimmune.com Semrush global rank: 8.17 M Semrush visits lastest month: 359
Unable to get host informations!!!
More informations about "TeraImmune" on Search Engine
TeraImmune - Crunchbase Company Profile & Funding
Organization. TeraImmune. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. About. TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. Acquired by. Baudax …See details»
Baudax Bio Acquires TeraImmune, Inc. - GlobeNewswire
MALVERN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq:BXRX) (“Baudax Bio” or the “Company”), a pharmaceutical company focused on innovative …See details»
TeraImmune Receives FDA IND Clearance to Initiate Phase
GERMANTOWN, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on discovery and development of novel Treg-based cell …See details»
TeraImmune, Inc | LinkedIn
TeraImmune, Inc | 735 followers on LinkedIn. A startup company developing Treg cell therapeutics First-in-human investigation for refractory Hemophilia A | Key technical …See details»
Baudax Bio Announces Corporate Update
MALVERN, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on developing T cell receptor (“TCR”) therapies utilizing human regulatory T cells (“Tregs”), as well as a portfolio of clinical stage Neuromuscular Blocking Agents (“NMBs”) and an associated reversal a...See details»
TeraImmune Team-up That Will Aid MS Treg Therapies Extended
Jan 6, 2023 TeraImmune is a biotechnology company working to develop new Treg-based therapies, made by equipping natural or lab-made Tregs with a disease-specific receptor …See details»
Baudax Bio Acquires TeraImmune, Inc. - Yahoo Finance
MALVERN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq:BXRX) (“Baudax Bio” or the “Company”), a pharmaceutical company focused on innovative …See details»
TeraImmune Receives FDA IND Clearance to Initiate Phase 1/2a …
GERMANTOWN, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on discovery and development of novel Treg-based cell …See details»
TeraImmune Extends CRADA for Development of Treg …
Jan 4, 2023 TeraImmune, Inc. is a biotechnology company that develops innovative immune-cell therapies. The Company is leveraging a dual Treg manufacturing platform …See details»
TeraImmune Presented Research on TREGable™ Technology at …
GERMANTOWN, Md., Nov. 18, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on the discovery and development of novel Treg-based …See details»
TeraImmune Presented Research on TREGable™ Technology at …
GERMANTOWN, Md., Nov. 18, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on the discovery and development of novel Treg-based …See details»
TeraImmune Extends CRADA for Development of Treg …
GERMANTOWN, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on the discovery and development of novel regulatory T-cell- (Treg)-based cell therapies for...See details»
Baudax Bio acquires biotechnology firm TeraImmune
Jul 3, 2023 TeraImmune develops new regulatory T cell (Treg)-based cell therapies to treat autoimmune ailments. The merged business will expedite TeraImmune’s immune …See details»
Teraimmune Company Profile 2024: Valuation, Investors, …
Contact Information. site. www.teraimmune.com. Ownership Status. Acquired/Merged. Financing Status. Formerly VC-backed. Primary Industry. Biotechnology. Other …See details»
TeraImmune - Funding, Financials, Valuation & Investors
TeraImmune has raised a total of. $3M. in funding over 2 rounds. Their latest funding was raised on Dec 22, 2022 from a Debt Financing round. TeraImmune is funded by Shinhan …See details»
Baudax Bio acquires TeraImmune - 2023-06-30 - Crunchbase
Jun 30, 2023 Overview. Acquired Organization: TeraImmune TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. …See details»
TeraImmune Receives FDA IND Clearance to Initiate Phase 1/2a …
GERMANTOWN, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on discovery and development of novel Treg-based cell …See details»
‘Treg’ cell therapy: bringing CAR-T to autoimmune disease
Aug 16, 2022 Over the past four years, a group of biotechnology companies have formed to develop these treatments, known as regulatory T cell, or “Treg,” therapies. Several …See details»
TeraImmune | VentureRadar
Location: USA. Founded in 2016. Acquired. Develops innovative immune-cell therapies by programming regulatory T cells to selectively suppress unwanted immune reactions, …See details»
TeraImmune - Contacts, Employees, Board Members, Advisors
Organization. TeraImmune. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 3. Contacts 12. About. …See details»